SELLAS Life Sciences Group, Inc. (SLS)
7.69
-0.29
(-3.63%)
USD |
NASDAQ |
Jun 09, 15:36
SELLAS Life Sciences Group EPS Diluted (Quarterly) : -0.0487 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Savara, Inc. | -0.1472 |
| Marker Therapeutics, Inc. | -0.1646 |
| Rezolute, Inc. | -0.1554 |
| KalVista Pharmaceuticals, Inc. | -0.4303 |
| BeyondSpring, Inc. | -0.0525 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -8.407M |
| Total Expenses (Quarterly) | 8.407M |
| Enterprise Value | 1.341B |
| Earnings Yield | -2.97% |
| Normalized Earnings Yield | -2.970 |